BioLife Solutions, Inc.
BLFS
$20.12
-$0.55-2.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 621.00K | -15.84M | -448.00K | 12.46M |
| Total Depreciation and Amortization | -- | 1.34M | 1.38M | 1.38M | 1.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 7.14M | 21.74M | 4.55M | -13.38M |
| Change in Net Operating Assets | -- | -2.99M | 85.00K | -3.76M | 857.00K |
| Cash from Operations | -- | 6.10M | 7.37M | 1.73M | 1.65M |
| Capital Expenditure | -- | -3.68M | -1.91M | -425.00K | -802.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -2.29M | -37.63M | -26.75M | 74.44M |
| Cash from Investing | -- | -5.97M | -39.53M | -27.18M | 73.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -2.50M | -2.50M | -2.50M | -3.43M |
| Issuance of Common Stock | -- | 0.00 | 18.00K | -- | 65.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -58.00K | -396.00K | -492.00K | -725.00K |
| Cash from Financing | -- | -2.56M | -2.88M | -2.99M | -4.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 29.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -2.42M | -35.04M | -28.44M | 71.23M |